Skip to main content
. 2020 Oct 20;2020(10):CD004908. doi: 10.1002/14651858.CD004908.pub3

Comparison 12. Ketorolac different doses.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
12.1 Adequate pain relief as reported by the woman 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
12.1.1 Ketorolac 5 mg versus Ketorolac 10 mg 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
12.2 Need for additional pain relief 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
12.2.1 Ketorolac 5 mg versus Ketorolac 10 mg 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
12.3 Maternal adverse events 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.86 [0.33, 2.25]
12.3.1 Ketorolac 5 mg vs Ketorolac 10 mg 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.86 [0.33, 2.25]